Antileishmanial effect of allopurinol - PubMed (original) (raw)

Antileishmanial effect of allopurinol

M A Pfaller et al. Antimicrob Agents Chemother. 1974 May.

Abstract

Allopurinol (4-hydroxypyrazolo[3,4-d]pyrimidine) has been shown to inhibit the growth of Leishmania braziliensis in vitro at concentrations which are attainable in human tissues and body fluids. This compound is believed to act by interdicting the de novo synthesis of pyrimidines, probably through the formation of allopurinol ribotide. Its lack of toxicity makes it a potential candidate for animal experimentation and it may serve as a prototype for other agents with similar mechanisms of action.

PubMed Disclaimer

References

    1. Ergeb Physiol. 1965;56:1-66 - PubMed
    1. Exp Parasitol. 1967 Feb;20(1):51-5 - PubMed
    1. Biochem Pharmacol. 1966 Jul;15(7):863-80 - PubMed
    1. Arch Biochem Biophys. 1966 Aug;115(2):401-6 - PubMed
    1. J Protozool. 1968 Feb;15(1):201-7 - PubMed

MeSH terms

Substances

LinkOut - more resources